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Introduction: Psoriasis is a chronic inflammatory, immune-mediated, provocative, and challenging skin 
condition. It is a non-contagious but debilitating disease and a leading cause of socioeconomic burden on the 
health system. 
Objective: To evaluate the role of antioxidant levels, lipid peroxidation status, and lipid profile in the etiology 
and degree of severity of psoriatic illness among psoriasis patients presenting in the Dermatology Department. 
Material and Methods: One hundred and twenty cases (n=130) of already diagnosed psoriasis patients were 
randomly and fifty healthy matched controls (n=50) of the same age and gender were included from the general 
population for comparison. Lipid profiles including serum total cholesterol, TG, HDL-c, and LDL-c levels were 
measured by enzyme colorimetric analysis on Micro Lab 300 (Merck & Germany). Antioxidant status SOD and 
lipid peroxidation status MDA was measured by the ELISA technique. Statistical analysis was performed using 
SPSS software Version 16. In this analysis, a “p” value of less than 0.05 was considered to be significant. 
Results: The study showed significantly elevated levels of MDA, serum TG, total cholesterol, and LDL-c levels in 
psoriatic patients in comparison with controls, whereas SOD levels and HDL-c levels were found to be 
significantly lower in psoriatic patients as compared to normal healthy matched controls.  
Conclusion: The findings of this study support the hypothesis that an imbalance in the oxidant-antioxidant 
system may play a role in the etiology of psoriasis and the degree of severity of its presentation. The study also 
concluded that dyslipidemia was an observed risk factor for the development of cardiovascular diseases in 
psoriatic patients.  
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Introduction 
 
Psoriasis is a chronic inflammatory, immune-
mediated, provocative, and challenging skin condition. 
It is a non-contagious but debilitating disease and a 
leading cause of socioeconomic burden on the health 
system. It is characterized by red patchy lesions with 
grey, silvery whitish lines. Psoriatic rash classically 
presents on elbows, scalp, knees, nails, joints, and 
other parts of the body that may often be painful and 
pruritic when severe.1 Skin cells multiply and normally 
as they get older they shed off and are replaced by 
new cells; whereas, in psoriasis, skin cell production is 
increased many folds.2 Psoriasis can be classified as 
psoriasis vulgaris, guttate psoriasis, erythrodermic 
psoriasis, and pustular psoriasis.3 
Psoriasis affects around 2% population of the world. 
According to the World Health Organization, about 
125 million people around the world suffer from this 
disease, and among them only about half of the new 
cases are reported annually.4 Around 4.6% of the 
American population is affected by psoriasis, lower 
figures are found among Indians (0.7%) whereas 
significantly higher prevalence rates have been 
reported in Kazakistan.5 
Psoriasis is an idiopathic clinical syndrome with multi-
organ involvement. It has been postulated to be 
strongly associated with the abnormalities in essential 
fatty acid metabolism1, lymphokine secretion, and 
oxidative stress/oxygen-related stress. New evidence 
has proposed that elevated reactive oxygen species 
(ROS) generation and reduced function of the 
antioxidant system may play a vital role in the 
pathophysiology of this disease. Dyslipidemia has 
been detected in the earlier stages of the development 
of psoriasis.6 Psoriasis is a multi-factorial illness 
determined by both genetic and environmental 
influences; also associated with it are abnormal lipid 
profile, a rise in oxidative stress, and decreased 
antioxidant capacity. Scientific evidence strongly 
suggests an association of psoriasis with risk factors 
including hypertension, obesity, and diabetes mellitus, 
etc.7 Chronic inflammation, which is a characteristic 
feature of psoriasis, may have a crucial role in the 
development and progression of dyslipidemia.8 An 
increase in ROS production during the inflammatory 
process in psoriasis may result in a reduction of 
antioxidant mechanisms that lead to lipid 
peroxidation.9,10 
Psoriasis presents with abnormalities in lipid profile, 
depletion of antioxidants defense mechanism with 
enhanced lipid peroxidation that in turn promote 
atherogenesis. Hence we have attempted to evaluate 
serum lipid profile, serum antioxidant levels, and lipid 
peroxidation status of psoriasis patients. 
 
Materials and Methods 
 
The present research was carried out as a case-control 
study, carried out in the Department of Biochemistry, 
Basic Medical Sciences Institute (BMSI) Jinnah Post 
Graduate Medical Centre (JPMC) Karachi in 
collaboration with the Department of Biochemistry, 
Khyber Medical College, Peshawar. The study 
duration was 9 months after its approval from 
concerned authorities. Ethical approval was obtained 
from the Ethical Review Committee of BMSI, JPMC 
Karachi. 
Informed consent was obtained from all participants 
taking part in the study. Proposed performa was used 
to collect the baseline data including age, gender, 
occupation, the ethnicity of the participants. Detailed 
medical history and relevant investigations were 
carried out as part of the methodology. Healthy 
individuals were matched as controls for comparison. 
Inclusion Criteria: Diagnosed psoriatic patients were 
recruited in the study from the Department of 
Dermatology JPMC Karachi. 
Exclusion Criteria: Those who were found to be 
alcoholics, smokers, hypothyroid, patients with liver 
disease or kidney disease,  other skin diseases, and 
those who refused to be a part of the study were 
excluded.  
Laboratory investigations e.g. lipid profile including 
serum total cholesterol, triglycerides (TG), high-
density lipoprotein cholesterol (HDL-c), low-density 
lipoprotein cholesterol (LDL-c) were tested by 
enzymatic colorimetric method on Micro Lab 300 
(Merck & Germany). Antioxidant status was measured 
using superoxide dismutase (SOD) and lipid 
peroxidation status using malondialdehyde (MDA) 
assay was carried out by ELISA method. Non-
probability purposive sampling techniques were used 
in this study. Blood samples of subjects who fulfilled 
the criteria were collected after an overnight fast of 10-
12 hours. A strictly pre-defined protocol was used for 
sample collection, storage, and analysis.   
Statistical analysis was carried out using SPSS 
software Version 16. The results of lipid tests, 
antioxidant, and lipid peroxidation status markers 
were expressed in Mean ± SD. The collected data was 
scrutinized with student’s t-test to evaluate the 
difference between the patients and controls. p values 
< 0.05 were considered statistically significant. 




There was a statistically significant reduction in the 
mean serum (SOD) superoxide dismutase levels in 
moderate and severe psoriasis groups when compared 
to the control group (p < 0.004). Whereas a statistically 
significant increase was noted in the mean serum 
malondialdehyde assay (MDA) levels in mild, 
moderate, and severe psoriasis groups in contrast to 
controls (p<0.01). The same can be seen in Figure 1.  
Comparison of Lipid Profile among Psoriatic 
Patients and Healthy individuals as Controls 
The mean + SD serum total cholesterol level of the 
severe psoriasis group was found to be significantly 
elevated when compared with the control group and 
mild psoriasis and moderate psoriasis groups (p<0.01). 
The mean serum triglyceride levels were markedly 
raised in the severe psoriasis group as compared with 
the control group, mild psoriasis group, and moderate 
psoriasis groups (p<0.01). The mean + HDL-c levels 
were notably reduced in the severe psoriasis group in 
comparison with the control group, mild psoriasis, and 
moderate psoriasis groups (p<0.005). The mean + SD 
LDL-C levels were significantly raised in the severe 
psoriasis group when matched with the control group, 
mild psoriasis group, and moderate psoriasis groups 
(p<0.005). 
 
Table 1: Comparison of Biochemical Variables 





































13.3 ± 2.8 29.8 ± 
14.4*□∆ 
* Statistically highly significant as compared to 
Controls p < 0.004  
□ Statistically significant as compared to Mild 
Psoriasis    p < 0.05 
∆ Statistically significant as compared Moderate 
Psoriasis p < 0.05 
☼ Statistically significant as compared to Severe 
Psoriasis   p < 0.01  
 
 
Figure 1: Comparison of Serum SOD, MDA among 
the Control & Patient Groups 
 




























193 ± 42.7 235.1 
± 35*□∆ 
























* Statistically significant as compared to Controls 
p<0.05  
 □ Statistically significant as compared to Mild 
Psoriasis  p<0.005 
 ∆ Statistically significant as compared to Moderate 
Psoriasis p<0.05 
 ☼ Statistically significant as compared to Severe 
Psoriasis p<0.01 
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Figure 2: Distribution & Comparison of Lipid Profile 




Lipid peroxidation can be determined through various 
methods as ROS provoke oxidation of polyunsaturated 
fatty acids (PUFA) in the biological system which can 
be measured with lipid peroxidation markers like 
MDA, Glutathione, and SOD. In psoriasis, it has been 
investigated by various researchers and almost all are 
in agreement that this stress affects all patients 
irrespective of their age, length, and severity of the 
disease, diet, and BMI, etc. whereas total antioxidant 
status in psoriatic patients indicates the aggravation of 
the disease. In this study, we found a significant 
increase in mean serum MDA levels in psoriatic 
patients when compared to controls (p < 0.05), mainly 
because lipid peroxidation, is implicated in the 
pathogenesis of psoriasis. Similar findings have been 
suggested by national and international studies e.g. 
Nast A, et al. (2015)1 elaborated this trend of increased 
serum MDA levels in psoriatic patients as compared to 
controls. In another study, Elhaddad and colleagues 
(2017) observed some disturbances in the serum levels 
of trace elements and total antioxidant status of 
patients with psoriasis.11 
In our study, we have also established a positive 
correlation between serum MDA levels and the 
progression of the disease. The possible mechanism of 
the increased MDA levels in oxidative stress might be 
due to the increased ROS activity of Phospholipase A₂ 
causing peroxidation of Arachidonic acid with the 
help of mediators that lead to increased production of 
MDA. In contrast to our findings, Augustin et al. 
(2016)12 reported no remarkable dissimilarity in serum 
MDA levels among psoriatic cases and controls.  
In our study, mean SOD levels were found to be 
significantly lower in psoriatic patients in contrast to 
controls (p<0.05). These results correlate with the 
findings of previous studies like (Mawla et al. (2013)13. 
Lower levels of antioxidant SOD were observed in 
psoriatic patients particularly in the severe psoriasis 
category. The reason for lower levels of antioxidant 
SOD could be due to its utilization in reducing the 
inflammatory markers. In contradiction to our study, 
Menter et al., (2008)14 found no significant variation in 
serum SOD levels between psoriatic cases and 
controls.  
On evaluating the lipid profile, we found a significant 
elevation in mean total cholesterol levels in psoriatic 
patients when compared to controls (p<0.05). Similar 
findings were reported by Latha and Kumar (2014)15 
Bhatia et al., (2014)16 and Khan et al., (2017).17 We also 
found a significant elevation in the mean triglyceride 
levels in psoriatic patients when compared to controls 
(p<0.05); Ghafoor et al., (2015)18 reported similar results 
although Arora et al., (2015)19 found no significant 
difference in triglyceride levels among psoriatic 
patients when compared to controls. 
Our study also showed a significant reduction in mean 
HDL-c levels in psoriatic patients when compared to 
controls (p<0.05). This finding has been supported by 
Arora et al., (2015)19 and Augstin et al., (2016)12, 
whereas Dsouza and Kuruville (2013)20 reported no 
significant difference in HDL-c levels among psoriatic 
patients and controls. Mean LDL-c levels in psoriatic 
patients were found to be significantly elevated in our 
study when compared to controls (p<0.05). This 
finding has been supported by Arora et al., (2015)19, 
and Bhatia and coworkers (2014)16 while other studies 
such as Latha and colleagues (2014)15 found no 
significant difference in LDL-c levels between psoriatic 





In conclusion, the results of this study showed that an 
imbalance in the oxidant/antioxidant status might be 
implicated in the pathogenesis of psoriasis. In 
addition, the findings of this study support the 
previous research studies in concluding that 
hyperlipidemia is markedly more common in psoriasis 
patients as compared to their healthy control 
counterparts in the community. Both these factors may 
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Based on these findings, it is recommended that early 
detection and management of hyperlipidemia should 
be considered in psoriasis patients to avoid early or 
late complications.  It will be effective in reducing the 
morbidity and mortality associated with the disease. 
Furthermore, based on the findings of this study, 
antioxidant supplementation is recommended to 
inactivate free radicals. This could be highly effective 
in preventing further new epidermal destruction, 
thereby reducing the severity and progression of the 
disease. 
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